Rocklage Scott M's Form 4 filing
scPharmaceuticals Inc. (SCPH) · filed Apr 13, 2022
- Accession no.
- 0001209191-22-024292
- Filed
- Apr 13, 2022, 4:51 PM ET
- Trade date
- Apr 11, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.35M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rocklage Scott MCIK 0001219014 | 10% Owner |
| Diekman John DCIK 0001240357 | 10% Owner |
| 5AM Partners IV, LLCCIK 0001589314 | 10% Owner |
| 5AM Ventures IV, L.P.CIK 0001589315 | 10% Owner |
| 5AM Co-Investors IV, L.P.CIK 0001593361 | 10% Owner |
| Schwab Andrew J.CIK 0001598549 | 10% Owner |
| 5AM Opportunities I, L.P.CIK 0001753000 | 10% Owner |
| 5AM Opportunities I (GP), LLCCIK 0001790778 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | Common Stock | SSaleDisposed | −220,096 | $5.00 | −$1,100,480 | 2,903,207 | Indirect | |
| Apr 11, 2022 | Common Stock | SSaleDisposed | −9,171 | $5.00 | −$45,855 | 120,966 | Indirect | |
| Apr 11, 2022 | Common Stock | SSaleDisposed | −40,733 | $5.00 | −$203,665 | 537,301 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.